ADIL Adial Pharmaceuticals Inc

Price (delayed)

$4.04

Market cap

$10.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$15.46

Enterprise value

-$18.1M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders. The Company's lead investigational new drug product, AD04, is a selective serotonin-3 ...

Highlights
Adial Pharmaceuticals's quick ratio has surged by 85% QoQ and by 15% YoY
The company's EPS has shrunk by 75% QoQ but it rose by 42% YoY

Key stats

What are the main financial stats of ADIL

ADIL stock price

How has the Adial Pharmaceuticals stock price performed over time
Intraday
-3.81%
1 week
-22.9%
1 month
-35%
1 year
-53.02%
YTD
-26.55%
QTD
57.81%

Financial performance

How have Adial Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$57.68M
Net income
-$57.8M
Gross margin
N/A
Net margin
N/A

Price vs fundamentals

How does ADIL's price correlate with its fundamentals

Growth

What is Adial Pharmaceuticals's growth rate over time

Valuation

What is Adial Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 75% QoQ but it rose by 42% YoY

Efficiency

How efficient is Adial Pharmaceuticals business performance

Dividends

What is ADIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADIL.

Financial health

How did Adial Pharmaceuticals financials performed over time
Adial Pharmaceuticals's quick ratio has surged by 85% QoQ and by 15% YoY
ADIL's current ratio has surged by 77% since the previous quarter and by 12% year-on-year
Adial Pharmaceuticals's debt is 100% more than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.